Nottingham Respiratory Research Unit

Nottingham Respiratory Research Unit The Nottingham Respiratory Research Unit conducts world leading research into respiratory conditions

We are one of the leading respiratory research units in the UK and the Respiratory Theme the National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre. Our organisation is a collaboration between Nottingham University Hospitals NHS Trust and the University of Nottingham. In addition, we are very grateful for the support overtime from Nottingham Hospitals Charity. Our fund

ers give us the support to facilitate the translational respiratory research. Our team consists of both academic and clinical researchers. Highly skilled and experienced nurses and administrative staff make up an exceptional team. We have close links on respiratory themes with researchers within other research groupings in Nottingham such as epidemiology, molecular microbiology, drug discovery, allergy, immunology and child health. We are also part of several major national/international collaborations (eg MRCMAP COPD, NIHR TRP in inflammatory diseases and UBIOPRED IMI consortia working closely with industry and major academic institutions and also host the National Centre for research into lymphangiolyomyomatosis (LAM). WHAT DO WE DO

The NRRU is dedicated to delivering high quality, patient-centred research, in order to advance knowledge and improve health outcomes for people with respiratory conditions such as Asthma, COPD and IPF. By Integrating research with clinical care has established us as one of the leading respiratory research units in the UK, with a proven track record of successful participant recruitment and positive participant experience. We achieve this by:
Active and meaningful patient and public involvement and engagement in our research to ensure they are at the heart of everything we do. Performing specialised tests in our state of the art facilities. Providing a safe environment with a highly skilled, professional team. Maintaining and expanding our extensive research volunteer database. Continuing international collaborations with leading researchers in the respiratory field.

We have recently commenced a new study sponsored by Avalyn Pharma and led at Nottingham University Hospitals by Dr Sy Gi...
19/07/2025

We have recently commenced a new study sponsored by Avalyn Pharma and led at Nottingham University Hospitals by Dr Sy Giin Chong.

New Placebo-Controlled Study of Inhaled Pirfenidone in Progressive Pulmonary Fibrosis.

The Sponsor is developing AP01 (also referred to in this document as the “study drug”) for use in the treatment of Progressive Pulmonary Fibrosis. AP01 is an experimental drug that may slow your PPF symptoms. You will inhale the study drug using the eFlow Nebuliser System.

New Study now commenced led by Dr Helen Barr.Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Si...
26/06/2025

New Study now commenced led by Dr Helen Barr.

Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Single-Ascending Doses in Healthy Participants and Multiple-Ascending Doses and Proof-of-Concept in Participants with CF

Evaluating the Safety, Tolerability, and Biodistribution of RCT2100 with Single-Ascending Doses in Healthy Participants and Multiple-Ascending Doses and Proof-of-Concept in Participants with CF

We are thrilled to share that our research lung physiologist Paula Almeida has been selected as the Expert from the Unit...
03/03/2025

We are thrilled to share that our research lung physiologist Paula Almeida has been selected as the Expert from the United Kingdom to join the World Health Organization's Asthma Guidelines Development Group (Asthma GDG).

This recognition acknowledges her 17 years of dedication to the study of respiratory physiology and global asthma care. She is particularly proud to be the only Physiotherapist in the group.

Paula tells us “It is a privilege to be part of this exceptional group of Global Experts.”

If you are interested in exploring more, you can find the brief biographies of the group members on the WHO CRD webpage:

The most common chronic respiratory diseases are asthma and chronic obstructive pulmonary disease (COPD).

Well done Suzanne & Hollie https://www.facebook.com/share/p/185G2MrmVu/?mibextid=wwXIfr
28/02/2025

Well done Suzanne & Hollie
https://www.facebook.com/share/p/185G2MrmVu/?mibextid=wwXIfr

Suzanne Swann and Hollie Gorensweigh at the NIHR Nottingham Biomedical Research Centre stand at QMC main entrance this morning, supporting Rare Disease Day and increasing awareness. Thank you and hope you had a great time!

Today is Rare Disease Day.
28/02/2025

Today is Rare Disease Day.

The Nottingham Biomedical Research Centre (BRC) is improving the health of millions of people with common diseases like asthma, depression and arthritis.

Day 12 of our 12 days of Christmas at NRRU:Our final day is a thank you for everyone's continued support. We look forwar...
24/12/2024

Day 12 of our 12 days of Christmas at NRRU:
Our final day is a thank you for everyone's continued support. We look forward to bringing our research through to 2025 and beyond. Merry Christmas and a fantastic New Year!

Day 11 of our 12 days of Christmas at NRRU:We tried desperately to somehow fit one of the numbers to this but alas we co...
23/12/2024

Day 11 of our 12 days of Christmas at NRRU:
We tried desperately to somehow fit one of the numbers to this but alas we couldn't but fortunately Dr. Lim still gets a day dedicated to himself. Dr. Wei Shen Lim worked on COVID-19 and advised the UK government during the pandemic for which he greatly deserves his honorary knighthood.

Day 10 of our 12 days of Christmas at NRRU:Day 10 is for for the year we opened our research unit. On the 9th of June 20...
22/12/2024

Day 10 of our 12 days of Christmas at NRRU:
Day 10 is for for the year we opened our research unit. On the 9th of June 2010 we opened our doors for the first time. We still have some of our founding members of staff including Tina, Norma, Katherine and Hellen and we're ever evolving and improving.

Day 9 of our 12 days of Christmas at NRRU:Day 9 is for the £9,000,000 secured by Simon Johnson for the new national rese...
21/12/2024

Day 9 of our 12 days of Christmas at NRRU:
Day 9 is for the £9,000,000 secured by Simon Johnson for the new national research centre. This new centre involving researchers from the NIHR Nottingham Biomedical Research Centre and led by the University of Nottingham will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases.

Day 8 of our 12 days of Christmas at NRRU:Day 8 is for our 8 COPD studies opened this year lead by Prof. Charlotte Bolto...
20/12/2024

Day 8 of our 12 days of Christmas at NRRU:
Day 8 is for our 8 COPD studies opened this year lead by Prof. Charlotte Bolton and Dr. Sam Kemp. Our C-FIND study is the first of its kind in Nottingham to utilise the mobile research unit. The study researches whether a lung check, done in the community using a mobile clinical area, of people at risk of COPD is acceptable and useful.

Day 7 of our 12 days of Christmas at NRRU:Day 7 is for the 7 interstitial lung disease and idiopathic pulmonary fibrosis...
19/12/2024

Day 7 of our 12 days of Christmas at NRRU:
Day 7 is for the 7 interstitial lung disease and idiopathic pulmonary fibrosis studies being lead by Dr. Gauri Saini and the team of research nurses. This rare chronic lung disease which causes irreversible scarring and research into this area is vital for understanding new treatments.

Address

Nottingham

Opening Hours

Monday 8:30am - 4:30pm
Tuesday 8:30am - 4:30pm
Wednesday 8:30am - 4:30pm
Thursday 8:30am - 4:30pm
Friday 8:30am - 4:30pm

Telephone

+441158404844

Website

http://www.nuh.nhs.uk/research

Alerts

Be the first to know and let us send you an email when Nottingham Respiratory Research Unit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Nottingham Respiratory Research Unit:

Share

Category